A novel stimulus, oncogene, induces expression of CD80 (B7-1) gene

Tumor Biology

Volumn 20, Issue 4, 1999, Pages 193-201

  Zhang, Haiying ^a   Haasch, Deanna ^a   Patterson, Bob ^a   Dickinson, Bob ^a   Kifle, Lemma ^a   Fry, Dennis G ^a   Okasinski, Gregory F ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Costimulatory molecules; Fibroblasts; Oncogenes; Transgene

Indexed keywords

B7 ANTIGEN; LUCIFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; GENE INDUCTION; MOUSE; NONHUMAN; ONCOGENE K RAS; ONCOGENE MYC; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; VIRUS ONCOGENE;

EID: 0033065856     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030063     Document Type: Article

References (20)

1. Allison JP: CD28-B7 interactions in T-cell activation. Curr Opin Immunol 1994;6:414-419.
2. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zanvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1995;80:707-718.
3. Miller SD, Vanderlugt CL, Bluestone JA: Blockade of CD28/B7 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995;3:739-745.
4. Bretscher P, Cohn MA: Theory of self-nonself discrimination. Science 1970;169:1042-1049.
5. Ding L, Shevach EM: Activation of CD4+ T cells by delivery of the B7 constimulatory signal on bystander antigen-presenting cells (trans-co-stimulation). Eur J Immunol 1994; 24:859-866.
6. Yellin MJ, Sinning J, Covey LR, Sherman W, Lee JJ, Glickman-Nir E, Sippel KC, Rogers J, Cleary AM, Parker M: T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1 ) and enhance their costimulatory activity. J Immunol 1994;153:666-674.
7. Watts TH, Alaverdi N, Wade WF, Linsley PS: Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction. J Immunol 1993; 150:2192-2202.
8. Goldstein MD, Debenedette MA, Hollenbaugh D, Watts TH: Induction of costimulatory molecules B7-1 and B7-2 in murine B cells: The CBA/N mouse reveals a role for Bruton's tyrosine kinase in CD40-mediated B7 induction. Mol Immunol 1996;33:541-552.
9. Schmittel A, Scheibenbogen C, Keilholz U: Lipopolysaccharide effectively up-regulates B7-1 (CD80) expression and costimulatory function of human monocytes. Scand Immunol 1995;42:701-704.
10. Yokochi T, Holly RD, Clark EA: B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J Immunol 1982;128:823-827.
11. Zhang H, Haasch D, Idler KB, Okasinski GF: Isolation and promoter mapping of the gene encoding murine co-stimulatory factor B7-1. Gene 1996;183:1-6.
12. Razi-Wolf Z, Freeman GJ, Galvin F, Benacerraf B, Nadler L, Reiser H: Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc Natl Acad Sci USA 1992;89:4210-4214.
13. Land H, Chen AC, Morgenstern JP, Parada LF, Weinberg RA: Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol Cell Biol 1986;6:1917-1925.
14. Morgan TL, Yang DJ, Fry DG, Hurlin PJ, Kohler SK, Maher VM, McCormick JJ: Characteristics of an infinite life span diploid human fibroblast cell strain and a near-diploid strain arising from a clone of cells expressing a transfected v-myc oncogene. Exp Cell Res 1991;197: 125-136.
15. Petropoulos CJ, Givol I, Hughes SH: Comparative analysis of the structure and function of the chicken c-myc and v-myc genes: v-myc is a more potent inducer of cell proliferation and apoptosis than c-myc. Oncogene 1996;12:2611-2621.
16. Kato GJ, Wechsler DS, Dang CV: DNA binding by the Myc oncoproteins. Cancer Treat Res 1992; 63:313-325.
17. Kinoshita T: Studies on transforming function fo Epstein-Barr virus-specific proteins. Hokkaido Igaku Zasshi 1990;65:362-375.
18. Chen SC, Redenius D, Schwartz RC: Tumorigenesis of a v-Ha-ras-expressing pre-B cell line selects for c-myc activation. Biochem Biophys Res Commun 1991;178:1343-1350.
19. Litz-Jackson S, Miller AH, Burgess GS, Boswell HS: Dissociation of nuclear events on P21 RAS transformation of FDC-P1 myeloid cells; c-jun/AP-1 expression versus c-myc transcription. Blood 1992;79:2404-2414.
20. Hodge JW, McLaughlin JP, Abrams SI, Shupert WL, Schlom J, Kantor JA: Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity. Cancer Res 1995;55:3598-3603.